CG Invites Co., Ltd.
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
083790 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
- Website:
- https://cginvites.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized precision medicine. Leveraging its core competency in developing novel chemical and biological drugs—such as Acelex (osteoarthritis), Ivaltinostat (pancreatic cancer), and Camrelizumab (immuno-oncology)—the company has expanded its focus to several key areas. These include whole genome sequencing, contributing to large-scale bio-data projects; the development of personalized, mRNA-based cancer vaccines targeting tumor-specific neoantigens; and digital therapeutics (DTx), exemplified by its HealthOnG platform for diabetes management. The company's strategy is to innovate within the digital genome market by integrating its drug development expertise with cutting-edge genomic and digital health technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.8 MB | ||
| 2025-08-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 34.7 KB | ||
| 2025-08-08 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.7 MB | ||
| 2025-07-25 00:00 |
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 16.5 KB | ||
| 2025-07-17 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-07-10 00:00 |
Legal Proceedings Report
소송등의판결ㆍ결정 (신주발행 무효-취하)
|
Korean | 5.3 KB | ||
| 2025-07-10 00:00 |
Regulatory News Service
소속부변경
|
Korean | 3.6 KB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 38.0 KB | ||
| 2025-07-01 00:00 |
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 14.1 KB | ||
| 2025-07-01 00:00 |
Regulatory News Service
소속부변경
|
Korean | 3.6 KB | ||
| 2025-06-05 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 134.5 KB | ||
| 2025-06-05 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 28.6 KB | ||
| 2025-06-05 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 29.4 KB | ||
| 2025-06-05 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.8 MB |
Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
